Parametric Portfolio Associates’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Parametric Portfolio Associates’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,209	Closed	-$313K	–	3644
2021 Q1	$313K	Buy	+5,209	New	+$189K	﹤0.01%	3699

Parametric Portfolio Associates's PAND Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 5,209 shares — an estimated $313K sold.

Parametric Portfolio Associates first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $313K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Parametric Portfolio Associates reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 5,209 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $313K.
Parametric Portfolio Associates first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Parametric Portfolio Associates's Pandion Therapeutics Inc. Common Stock position peaked at $313K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.